SB 2461 creates a new certification requirement for individuals practicing assisted reproductive technology (ART) in Tennessee, directly affecting fertility clinics and ART practitioners. It mandates the Department of Health to establish a certification process for these professionals, requiring them to obtain a certificate to legally provide ART services. Key provisions include prohibiting genetic testing of embryos except for chromosomal abnormalities or fatal fetal anomalies, requiring use of standardized consent forms with specific patient disclosures, and mandating certified technologists to comply within 60 days of the rules taking effect. The bill also establishes definitions for ART and certified technologists across multiple health licensing chapters.
SB 2055 requires Tennessee public schools and charter schools to permit private pay providers (licensed behavior analysts hired by families) to deliver applied behavior analysis services to students with autism or developmental delays during school hours. The bill mandates that schools allow access to students in classroom or educational settings, provided the services align with the student's individualized education plan (IEP) and parental consent is obtained. Schools must coordinate with IEP teams, ensure services don't disrupt classrooms, and cannot charge fees or block access to private providers. The law also requires private providers to comply with background checks and licensure standards, while prohibiting schools from discriminating against students receiving these services.
HB 2246 regulates stem cell therapies in Tennessee by requiring physicians performing such treatments (for orthopedics, wound care, or pain management) to source stem cells only from facilities registered with the FDA and accredited by specific organizations like the National Marrow Donor Program. The bill mandates that facilities provide detailed accreditation documentation to physicians and include a post-thaw viability report for each cell batch. Physicians must also disclose in all advertisements that the therapy is not FDA-approved and encourage patients to consult their primary care provider. The law explicitly excludes stem cell therapies derived from fetal or embryonic sources.
HB 2093 prevents managed care organizations (MCOs) from unilaterally ending contracts with qualified nursing facilities in Tennessee's TennCare program, except under specific circumstances. The bill gives the TennCare bureau exclusive authority to decide if a nursing facility can be terminated from the program, not the MCOs. MCOs must report concerns about facilities to the bureau instead of acting alone, and must continue services during the bureau's review. This changes how MCOs manage nursing facility contracts, ensuring only the bureau can approve terminations.
HB 29 requires health insurance companies to reimburse chiropractic physicians at the same rate as medical doctors for identical services, using the same payment methodology. It prohibits insurers from creating separate chiropractic codes or rates to avoid this requirement, applying to standard medical coding systems like CPT. The law directly affects chiropractors and insurers, but excludes state Medicaid (TennCare), CoverKids, and government-provided insurance. Key provisions mandate equal reimbursement calculations based on nationally recognized codes, with no impact on existing payment structures for exempt programs. The bill takes effect July 1, 2025.
SB 2032 requires Tennessee public safety employers (such as police departments, fire services, and emergency medical personnel) to provide employees and job applicants with reasonable access to their full employment records, including mental health evaluation results. If an applicant is denied employment based on a mental health evaluation, they can request the evaluation results and submit an alternative evaluation at their own expense, which the employer must review. The bill amends multiple Tennessee codes to implement these transparency requirements and allows employees to sue for violations, with the winning party recovering attorney fees. This law directly affects public safety workers and job seekers in roles involving protection of persons or property.
SB 2279 requires Tennessee's Department of Health to publish all inspection criteria used for pain management clinics on its website, making compliance standards transparent for clinics. It mandates that the department publicly share the criteria for identifying "high-risk" prescribers (based on patient overdose rates) and remove such designations after prescribers complete required training. The bill also exempts pain management specialists from the high-risk prescriber list and allows them to temporarily cover for medical directors without counting toward the four-clinic limit for medical directors. These changes directly affect pain management clinics, prescribers, and pain management specialists by clarifying regulatory expectations and providing pathways to address high-risk designations.
This bill is a House Joint Resolution that formally honors LifeSpring Community Health in Chattanooga for its twentieth anniversary. It recognizes the organization's growth from a small after-school clinic in 2006 to a full-service provider offering pediatric, community health, and behavioral care to thousands of children. The resolution acknowledges the organization's specific contributions, such as expanding services during the pandemic and adding bilingual mental health support for families in underserved neighborhoods. As a commemorative measure, the bill does not alter any laws or policies but serves to publicly commend the healthcare provider's dedication to the community.
HB 1984 expands access to buprenorphine treatment for opioid use disorder by allowing more healthcare providers to directly administer buprenorphine mono or buprenorphine without naloxone, as long as they act within their scope of practice. It specifically permits prescribing these medications to nursing mothers and patients with documented adverse reactions to naloxone, and clarifies that prescribing injectable forms doesn’t restrict providers from later prescribing non-naloxone buprenorphine. The bill amends Tennessee’s pharmacy law (TCA Title 53, Chapter 11) to remove barriers for these specific scenarios. This directly affects healthcare providers (like nurse practitioners or physician assistants) and patients seeking opioid treatment, particularly nursing mothers and those with allergies to naloxone.
SB 1389 prohibits healthcare providers participating in Tennessee's TennCare or CoverKids programs from refusing to treat patients solely because they decline vaccines or immunizations. It requires the state to stop reimbursing providers who violate this rule and mandates the TennCare director to create implementing regulations. The law excludes oncology and organ transplant specialists from the prohibition. The bill takes effect July 1, 2025, with rules to be established under state administrative procedures.
